Skip to main content
Clinical Trials/DRKS00030936
DRKS00030936
Recruiting
未知

Research project to test the efficacy of an online follow-up program for patients with anxiety disorder using randomized controlled designs

Sympatient GmbH0 sites414 target enrollmentDecember 14, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
F40.0
Sponsor
Sympatient GmbH
Enrollment
414
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 14, 2022
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sympatient GmbH

Eligibility Criteria

Inclusion Criteria

  • ? Presence of a primary diagnosed anxiety disorder (for RCT\-A: agoraphobia with/without panic disorder F40\.0\-/6B32; for RCT\-P: panic disorder F41\.0/6B34; for RCT\-S: social phobia F40\.1/6B34\).
  • ? Current, at least mild, anxiety symptomatology as measured by a summed score of at least 30 on the LSAS for the RCT\-S, or at least 8 on the PAS for the RCT\-A and RCT\-P at the time of baseline interview (T0\)
  • ? One prior psychotherapeutic treatment for the anxiety disorder completed within the past 12 months
  • ? No current medication for the anxiety disorder or medication stable for at least 4 weeks before inclusion
  • ? Presence of internet access and a device to use Invirto Aftercare.
  • ? Sufficient understanding of the German language
  • ? Willingness to use Invirto Nachsorge on their own responsibility.

Exclusion Criteria

  • ?Acute suicidality
  • ?Current ongoing psychotherapeutic treatment at baseline assessment
  • ?Diagnosis of schizophrenic or bipolar disorder
  • ?Contraindication to the Invirto aftercare medical device

Outcomes

Primary Outcomes

Not specified

Similar Trials